Transforming How Clinical Benefits are Achieved
AIM understands that breakthroughs happen when you engage the right people, promote innovative ideas, and provide access to cutting-edge research tools and resources. Our global initiatives are fundamentally changing the face and future of research to advance the discovery of the CURE.
AIM at Melanoma Research Efforts
Our International Melanoma Tissue Bank Consortium (IMTBC) is the first multi-institutional tissue bank of its kind for melanoma.
International Melanoma Working Group
Bringing together leading researchers to reshape the future of melanoma treatmentLearn More »
Brain Metastases Tissue Bank & Clinical Trial
Providing researchers with the resources needed to continue this important work
Collaborative Adaptive Trials (MICAT)
Creating collaborative among researchers and industry to find faster, more effective melanoma treatments
International Melanoma Tissue Bank Consortium
Creating the first international bank with fresh frozen primary melanoma tissue for public and private researchLearn More »
International Melanoma Tissue Bank Consortium (IMTBC)
- IMTBC is the first multi-institutional tissue bank of its kind for melanoma.
- IMTBC contains fresh frozen samples of primary melanoma tumor tissue for research.
- Researchers across the globe will have access to these vital tissues.
- AIM is paving the way for major advancements in the field of melanoma.